Australia markets open in 3 hours 25 minutes

Marker Therapeutics, Inc. (MRKR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.2000+0.1000 (+2.44%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 36.59M
Enterprise value 18.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.06
Price/book (mrq)2.60
Enterprise value/revenue 3.41
Enterprise value/EBITDA -1.27

Trading information

Stock price history

Beta (5Y monthly) 1.54
52-week change 3170.39%
S&P500 52-week change 323.57%
52-week high 39.6800
52-week low 31.1600
50-day moving average 34.2758
200-day moving average 34.4327

Share statistics

Avg vol (3-month) 318.3k
Avg vol (10-day) 313.24k
Shares outstanding 58.9M
Implied shares outstanding 68.9M
Float 86.75M
% held by insiders 112.15%
% held by institutions 122.75%
Shares short (15 Apr 2024) 464.43k
Short ratio (15 Apr 2024) 42.89
Short % of float (15 Apr 2024) 41.01%
Short % of shares outstanding (15 Apr 2024) 40.72%
Shares short (prior month 15 Mar 2024) 4149.7k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Sept 2016
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 327 Jan 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -248.76%
Operating margin (ttm)-278.06%

Management effectiveness

Return on assets (ttm)-35.36%
Return on equity (ttm)-83.47%

Income statement

Revenue (ttm)3.31M
Revenue per share (ttm)0.38
Quarterly revenue growth (yoy)39.20%
Gross profit (ttm)N/A
EBITDA -11.79M
Net income avi to common (ttm)-14.05M
Diluted EPS (ttm)-1.5900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.11M
Total cash per share (mrq)1.7
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.57
Book value per share (mrq)1.58

Cash flow statement

Operating cash flow (ttm)-16.44M
Levered free cash flow (ttm)-10.14M